By Associate Professor Ewan Kerr Alexander Millar

Journal articles

O’Toole S; Machakel D; Millar E; Nair R; Cooper C; Qiu MR; McLeod D; Sutherland R; Watkins N; Swarbrick A, 2012, '35. Hedgehog overexpression is regulated by stromal interactions and predicts for poor outcome in invasive ductal carcinoma', Pathology, 44, pp. S114 - S114, http://dx.doi.org/10.1016/s0031-3025(16)32927-0

Chow HT; Tran K; Millar EKA; Lynch J; Murrell DF, 2012, 'Diverse presentations of carcinoma erysipelatoides from a teaching hospital in australia.', Case Rep Dermatol Med, 2012, pp. 134938, http://dx.doi.org/10.1155/2012/134938

Reynolds R; Marjoniemi V; Millar E, 2012, 'Unusual renal tumours: a report of two interesting cases', Pathology, 44, pp. S91 - S92, http://dx.doi.org/10.1016/s0031-3025(16)32861-6

Afalnia S; Weatherall C; Millar E; Katz I, 2011, 'CASE REPORT: NEUTROPENIC FEVER WITH BK VIRUS NEPHROPATHY AND CYTOMEGALOVIRUS INFECTION IN A RENAL TRANSPLANT PATIENT', NEPHROLOGY, 16, pp. 79 - 79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294977600209&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

López-Knowles E; Zardawi SJ; McNeil CM; Millar EKA; Crea P; Musgrove EA; Sutherland RL; O’Toole SA, 2011, '40. Cytoplasmic localisation of β catenin is a marker of poor outcome in breast cancer patients', Pathology, 43, pp. S101 - S101, http://dx.doi.org/10.1016/s0031-3025(16)33328-1

McNeil CM; O’Toole SA; Millar EKA; Kench JG; Segara D; Morey AL; Lopez-Knowles E; Crea P; Henshall SM; Musgrove EA; Sutherland RL, 2011, '41. Differences in cell cycle and apoptotic biomarker expression between molecular subtypes of invasive ductal breast carcinoma', Pathology, 43, pp. S101 - S102, http://dx.doi.org/10.1016/s0031-3025(16)33329-3

López-Knowles E; O’Toole SA; McNeil CM; Millar EKA; Ru Qiu M; Crea P; Musgrove EA; Sutherland RL, 2011, '42. PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality', Pathology, 43, pp. S102 - S102, http://dx.doi.org/10.1016/s0031-3025(16)33330-x

Xu H; Yan M; Patra J; Natrajan R; Yan Y; Swagemakers S; Tomaszewski J; Millar E; Spek PVD; Reis-filho J; Ramsay RG; O'Toole S; Mcneil CM; Sutherland RL; McKay MJ; Fox SB, 2011, 'Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers', Breast Cancer Research, 13, pp. 1 - 10, http://dx.doi.org/10.1186/bcr2814

O'Toole S; Machalek DA; Shearer R; Millar E; Nair R; Schofield PR; McLeod D; Cooper CE; Mcneil CM; Mcfarland A; Nguyen A; Ormandy CJ; Qiu M; Rabinovich B; Martelotto L; Vu D; Hannigan GE; Musgrove EA; Christ DU; Sutherland RL; Watkins DJ; Swarbrick A, 2011, 'Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer', Cancer research, 71, pp. 4002 - 4014, http://dx.doi.org/10.1158/0008-5472.CAN-10-3738

O'Toole S; Millar E; Selinger CI; LUM T; Beith J, 2011, 'Molecular assays in breast cancer pathology', Pathology, 43, pp. 116 - 127, http://dx.doi.org/10.1097/PAT.0b013e3283430926

Millar E; Graham PH; Mcneil C; Browne L; O''Toole SA; Boulghourjian A; Kearsley J; Papadatos G; Delaney GP; Fox CH; Nasser E; Capp AL; Sutherland R, 2011, 'Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53panel, which includes Ki-67 and p53', British Journal of Cancer, 105, pp. 272 - 280, http://dx.doi.org/10.1038/bjc.2011.228

Yan M; Jene N; Byrne D; Millar E; O'Toole S; Mcneill CM; Bates GJ; Harris AL; Banham AH; Sutherland RL; Fox SB, 2011, 'Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers', Breast Cancer Research, 13, pp. 1 - 10, http://dx.doi.org/10.1186/bcr2869

Chan P; Moller A; Liu MCP; Sceneay J; Wong CSF; Waddell N; Huang KT; Dobrovic A; Millar E; O'Toole S; Mcneil CM; Sutherland RL; Bowtell DD; Fox S, 2011, 'The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through genecopy number in breast cancer and is associated with a basal-like phenotype and p53 expression', Breast Cancer Research, 13, pp. 1 - 10, http://dx.doi.org/10.1186/bcr2828

Katz I; Gill A; Brein L; Harvey M; Millar E; Brown M, 2010, 'ATHROMBOCYTOPENIC MICROANGIOPATHY AND RENAL FAILURE', NEPHROLOGY, 15, pp. 53 - 53, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18939

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18946

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18954

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18941

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18943

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18937

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18935

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18934

Blagosklonny M; Gudkov A, 2010, 'Introducing, OncoTarget', Oncotarget, 1, pp. 2 - 2, http://dx.doi.org/10.18632/oncotarget.18884

O’Toole SA; McNeil CM; Morey AL; Millar EK; Lopez-Knowles E; Musgrove EA; Sutherland RL, 2010, '29. c-MYC gene amplification is associated with a poor prognosis in invasive ductal carcinoma', Pathology, 42, pp. S89 - S90, http://dx.doi.org/10.1097/01268031-201042001-00200

Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole S; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Bagliettoe L; Giles GG; Bailey CG; Rasko JEJ; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; Mclean ; Mitchell CA, 2010, 'Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers', Proceedings of the National Academy of Sciences of the United States of America, 107, pp. 22231 - 22236, http://dx.doi.org/10.1073/pnas.1015245107

Yilmaz MH; Millar EK; Theocharous C; Graham PH, 2009, 'Metachronous bilateral primary low-grade mucosa-associated lymphoid tissue non-hodgkins lymphoma of the breast', Asia-Pacific Journal of Clinical Oncology, 5, pp. 154 - 158, http://dx.doi.org/10.1111/j.1743-7563.2009.01230.x

Millar E; Anderson LR; Mcneil CM; O Toole S; Pinese M; Crea P; Morey AL; Biankin AV; Henshall SM; Musgrove EA; Sutherland RL; Butt A, 2009, 'BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast', British Journal of Cancer, 100, pp. 123 - 133

Millar E; Dean J; Mcneil CM; O Toole S; Henshall SM; Tran T; Lin J; Quong A; Comstock C; Witkiewicz A; Musgrove EA; Rui H; Lemarchand L; Setiawan V; Haiman C; Knudsen K; Sutherland RL; Knudsen E, 2009, 'Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome', Oncogene, 28, pp. 1812 - 1820

Millar E; Inder SJ; Lynch JP, 2009, 'Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer - A potential diagnostic pitfall', Histopathology, 54, pp. 622 - 623

Yilmaz M; Millar E; Theocharous C; Graham PH, 2009, 'Metachronous bilateral primary low-grade mucosa-associated lymphoid tissue non-hodgkins lymphoma of the breast', Asia-Pacific Journal of Clinical Oncology, 5, pp. 154 - 158, http://dx.doi.org/10.111/j.1743-7563.2009.01230.x

Millar E; Graham PH; O Toole S; Mcneil CM; Browne L; Morey AL; Eggleton SA; Beretov J; Theocharous C; Capp A; Nasser EH; Kearsley J; Delaney GP; Papadatos G; Fox CH; Sutherland RL, 2009, 'Prediction of Local Recurrence, Distant Metastases, and Death After Breast-Conserving Therapy in Early-Stage Invasive Breast Cancer Using a Five-Biomarker Panel', Journal of Clinical Oncology, 27, pp. 4701 - 4708

Tan E; Yan M; Campo L; Han CG; Takano E; Turley H; Candiloro I; Pezzella F; Gatter K; Millar E; O Toole S; Mcneil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox S, 2009, 'The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy', British Journal of Cancer, 100, pp. 405 - 411

Wang Y; Dean J; Millar E; Tran T; Mcneil CM; Burd C; Henshall SM; Utama F; Witkiewicz A; Rui H; Sutherland RL; Knudsen K; Knudsen E, 2008, 'Cyclin D1b is aberrantly regulated in response to therapeutic challenge and promotes resistance to estrogen antagonists', Cancer research, 68, pp. 5628 - 5638

Millar EKA; Tran K; Marr P; Graham PH, 2007, 'p27^KIP-1 cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27^KIP-1 correlates with hormone receptor status but not with local recurrence', Pathology International, 57, pp. 183 - 189, http://dx.doi.org/10.1111/j.1440-1827.2007.02079.x

Whittaker J; Millar E; Blundell N, 2007, 'Trials in melanoma: Feeling the burn?', Good Clinical Practice Journal, 14, pp. 17 - 20

Millar E; Tran K; Marr P; Graham PH, 2007, 'p27KIP-1 cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP-1 correlates with hormone receptor status but not with local recurrence', Pathology International, 57, pp. 183 - 189

McNeil CM; Sergio CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar EKA; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt AJ; Henshall SM; Musgrove EA; Sutherland RL, 2006, 'c-Myc overexpression and endocrine resistance in breast cancer', Journal of Steroid Biochemistry and Molecular Biology, 102, pp. 147 - 155, http://dx.doi.org/10.1016/j.jsbmb.2006.09.028

Mcneil CM; Anderson LR; Inman CK; Eggleton SA; Murphy NC; Millar E; Crea P; Kench JG; Alles MC; Gardiner-Garden M; Ormandy CJ; Butt A; Henshall SM; Musgrove EA; Sutherland RL; Sergio CM, 2006, 'c-Myc overexpression and endocrine resistance in breast cancer', Journal of Steroid Biochemistry and Molecular Biology, 18, pp. 284 - 289

Dray M; McCarthy S; Palmer A; Bonar S; Stalley P; Marjoniemi V; Millar E; Scolyer R, 2006, 'Myopericytoma: a unifying term for a spectrum of tumours that show overlapping features with myofibroma. A review of 14 cases', Journal of Clinical Pathology, 59, pp. 67 - 73

Graham PH; Jagavkar R; Browne L; Millar E, 2006, 'Supraclavicular radiotherapy must be limited laterally by the coracoid to avoid significant adjuvant breast nodal radiotherapy lymphoedema risk', Journal of Medical Imaging and Radiation Oncology, 50, pp. 578 - 582

Murphy N; Millar E; Lee CS, 2005, 'Gene expression profiling in breast cancer: towards individualising patient management', Pathology, 37, pp. 271 - 277

Trevillian P; Paul H; Millar E; Hibberd A; Agrez MV, 2004, 'αvβ6 integrin expression in diseased and transplanted kidneys', Kidney International, 66, pp. 1423 - 1433, http://dx.doi.org/10.1111/j.1523-1755.2004.00904.x

Trevillian P; Paul H; Millar E; Hibberd AD; Agrez M, 2004, 'A(v)beta(6) integrin expression in diseased and transplanted kidneys', Kidney International, 66, pp. 1423 - 1433

Murugasu A; Miller J; Proietto A; Millar E, 2003, 'Extragenital mullerian adenosarcoma with sarcomatous overgrowth arising in an endometriotic cyst in the pouch of Douglas', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 13, pp. 371 - 375, http://dx.doi.org/10.1046/j.1525-1438.2003.13187.x

Millar EKA; Leong ASY, 2001, 'Significance and assessment of margin status in ductal carcinoma in situ of the breast', Advances in Anatomic Pathology, 8, pp. 338 - 344, http://dx.doi.org/10.1097/00125480-200111000-00004

Millar EKA; Beretov J; Sarris M; Lee CS, 2001, 'Mucinous differentiation in colonic adenocarcinoma is associated with a reduction in tumour-infiltrating lymphocytes', European Journal of Surgical Oncology, 27, pp. 273 - 277, http://dx.doi.org/10.1053/ejso.2000.1094

Millar EKA; Pepperall D; Lee CS; Forbes JF, 2001, 'Re: p53 protein detection in breast epithelium by immunohistochemistry [5]', Breast, 10, pp. 263 - 265, http://dx.doi.org/10.1054/brst.2000.0194

Millar EK; Beretov J; Sarris M; Clarke RA; Kearsley J; Lee CC, 2000, 'Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.', Histopathology, pp. 491 - 496

Millar EKA; Waldron S; Spencer A; Braye S, 1999, 'CD10 positive thyroid marginal zone non-Hodgkin lymphoma', Journal of Clinical Pathology, 52, pp. 849 - 850, http://dx.doi.org/10.1136/jcp.52.11.849

Millar EK; Cappelen-Smith C; Sarris M; Clarke RA; Kearsley J; Lee CC, 1998, 'Prognostic factors in cutaneous malignant melanoma', Cancer Forum, pp. 178 - 180

Back to profile page